| COVID-19 |
1 |
1 |
| Corticosteroids |
0 |
0.98 |
| Inhaled Corticosteroid |
0 |
0.99 |
| Asthma |
0 |
0.63 |
| Hospital |
0 |
0.35 |
| Pandemic |
0 |
0.35 |
| Metered-Dose Inhaler (MDI) |
0 |
0.24 |
| Pneumonia |
0 |
0.24 |
| Inhalers |
0 |
0.23 |
| Acute Respiratory Distress Syndrome |
0 |
0.16 |
| Biologic Therapy |
0 |
0.15 |
| Allergy |
0 |
0.12 |
| Clinical Guidelines |
0 |
0.12 |
| Community-Acquired Pneumonia |
0 |
0.12 |
| Face |
0 |
0.12 |
| Fellowship |
0 |
0.12 |
| Health Care Services |
0 |
0.12 |
| Immunization |
0 |
0.12 |
| Immunomodulator |
0 |
0.12 |
| Internship |
0 |
0.12 |
| Maryland |
0 |
0.12 |
| Meta-Analysis |
0 |
0.12 |
| Receptors |
0 |
0.12 |
| Transplant Evaluation |
0 |
0.12 |
| Viral Pneumonia |
0 |
0.12 |
| Erectile Dysfunction |
0 |
0.06 |
| Sepsis |
0 |
0.06 |
| Vaccines |
0 |
0.06 |